Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
859.6500 -20.60 (-2.34%)
NSE Apr 25, 2025 15:31 PM
Volume: 1.1M
 

859.65
-2.34%
KRChoksey
ZYDUSLIF reported slower revenue growth by 5.8% y-o-y (+3.1% Q-o-Q) to Rs. 45,052 Mn in Q3FY24,
which is slightly or 3.3% below the estimate of Rs. 46,577 Mn. The growth was lower than anticipated due to lower than expected growth in the US, Consumer Wellness and API segments.; partially offset by better than anticipated growth in India and Emerging Market formulation segments.
Zydus Lifesciences Ltd. is trading below all available SMAs
More from Zydus Lifesciences Ltd.
Recommended